STAT4 and breast carcinoma: Data analyses from The Cancer Genome Atlas (TCGA) indicate that high expression of the IL-12/STAT4 axis is associated with better survival rates in breast cancer patients, especially in more aggressive subtypes, while reduced STAT4 expression correlates with poorer prognoses [49].